(Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 1,742.03%1.13M | 97.39%-63K | -67.92%51K | -140.24%-1.63M | -69.30%693K | -113.97%-69K | -3,348.57%-2.41M | -88.41%159K | 207.28%4.05M | -48.19%2.26M |
Net income from continuing operations | 148.78%499K | 16.92%-751K | 4.25%-563K | -268.49%-2.92M | -385.21%-405K | -376.49%-1.02M | -583.42%-904K | -156.87%-588K | 34.03%1.73M | -70.17%142K |
Operating gains losses | --0 | ---- | ---- | -32.31%132K | --0 | --0 | --0 | 169.39%132K | 0.00%195K | 0.00%49K |
Depreciation and amortization | 300.00%156K | -9.52%38K | 7.89%41K | 5.92%161K | 10.53%42K | 2.63%39K | 10.53%42K | 0.00%38K | 0.00%152K | 65.22%38K |
Unrealized gains and losses of investment securities | 111.63%30K | -74.64%35K | -99.50%1K | 427.69%213K | 301.54%131K | ---258K | --138K | --202K | ---65K | ---65K |
Remuneration paid in stock | --0 | --0 | --0 | 1,336.36%158K | --0 | 5,000.00%153K | -40.00%3K | --2K | -96.30%11K | -98.69%3K |
Deferred tax | -855.91%-889K | -101.64%-2K | -146.15%-6K | 131.32%140K | 121.92%98K | ---93K | --122K | --13K | ---447K | ---447K |
Other non cashItems | 30.63%418K | 2.22%322K | 1.94%316K | 48.53%1.26M | 19.48%319K | 51.66%320K | 90.91%315K | 49.04%310K | 10.81%851K | 74.51%267K |
Change In working capital | 15.89%919K | 111.97%255K | 424.00%262K | -148.00%-779K | -77.62%508K | 548.02%793K | -315.20%-2.13M | 16.28%50K | 217.10%1.62M | -33.74%2.27M |
-Change in receivables | 4,645.16%1.47M | -49.58%179K | -3,090.91%-329K | -82.61%288K | 79.32%-109K | 104.96%31K | -61.16%355K | -99.42%11K | 146.23%1.66M | 80.35%-527K |
-Change in prepaid assets | -1,025.00%-45K | 104.87%48K | 184.43%499K | -368.87%-1.49M | 132.37%90K | -114.81%-4K | -516.25%-986K | -735.48%-591K | -115.20%-318K | -112.98%-278K |
-Change in payables and accrued expense | -226.71%-526K | 107.48%43K | 113.68%13K | -191.23%-1.99M | -167.80%-1.16M | -104.30%-161K | 83.85%-575K | -133.33%-95K | 153.26%2.18M | 151.54%1.71M |
-Change in other current assets | -98.53%19K | 98.85%-15K | -91.38%79K | 1,291.94%3.8M | 195.10%2.89M | 267.44%1.29M | -18,657.14%-1.3M | 1,507.02%916K | 155.49%273K | 261.18%980K |
-Change in other current liabilities | ---- | --0 | --0 | -200.00%-1.21M | ---- | ---- | -83.60%375K | 99.52%-11K | --1.21M | 1,991.67%3.77M |
-Change in other working capital | ---- | ---- | ---- | 94.67%-180K | --0 | --0 | --0 | ---180K | -172.04%-3.38M | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 1,742.03%1.13M | 97.39%-63K | -67.92%51K | -140.24%-1.63M | -69.30%693K | -113.97%-69K | -3,348.57%-2.41M | -88.41%159K | 207.28%4.05M | -48.19%2.26M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | -95.93%51K | 0 | 98.65%-51K | 80.83%-724K | -339K | 1.25M | -241K | -7,452.00%-3.78M | -29.89%-3.78M |
Net PPE purchase and sale | --0 | ---- | ---- | ---51K | --0 | --0 | ---- | ---- | --0 | --0 |
Net investment purchase and sale | --0 | --0 | --0 | --0 | 80.83%-724K | ---339K | --1.3M | ---241K | -7,452.00%-3.78M | ---3.78M |
Net other investing changes | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | -95.93%51K | --0 | 98.65%-51K | 80.83%-724K | ---339K | --1.25M | ---241K | -7,452.00%-3.78M | -29.89%-3.78M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -176.55%-802K | 275.17%1.01M | 62.66%-295K | -216.95%-1.99M | -111.06%-338K | -28.32%-290K | 34.77%-576K | -227.80%-790K | 146.03%1.71M | 550.59%3.06M |
Net issuance payments of debt | -682.19%-571K | 1,387.50%927K | -103.89%-72K | -46.43%1.63M | -102.18%-71K | -4.29%-73K | -4.35%-72K | 2,781.16%1.85M | 111.37%3.05M | 1,028.21%3.26M |
Net common stock issuance | --0 | ---- | ---- | --350K | --0 | --2.44M | ---- | ---- | --0 | --0 |
Net preferred stock issuance | ---- | ---- | --0 | ---2.44M | --0 | ---- | ---- | ---2.44M | --0 | --0 |
Cash dividends paid | --0 | --0 | --0 | 22.33%-626K | --0 | --0 | 7.28%-611K | 69.39%-15K | -313.33%-806K | 0.00%-49K |
Interest paid (cash flow from financing activities) | -6.45%-231K | -10.29%-268K | -18.62%-223K | -69.76%-915K | -73.38%-267K | -102.80%-217K | -56.77%-243K | -52.85%-188K | -18.46%-539K | 13.48%-154K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -176.55%-802K | 275.17%1.01M | 62.66%-295K | -216.95%-1.99M | -111.06%-338K | -28.32%-290K | 34.77%-576K | -227.80%-790K | 146.03%1.71M | 550.59%3.06M |
Net cash flow | ||||||||||
Beginning cash position | -19.92%1.26M | -92.05%261K | -87.95%504K | 89.49%4.18M | -67.13%872K | -34.13%1.57M | -1.65%3.28M | 89.49%4.18M | 800.82%2.21M | 84.75%2.65M |
Current changes in cash | 147.42%331K | 157.40%997K | 72.02%-244K | -285.47%-3.68M | -124.02%-369K | -360.45%-698K | -82.27%-1.74M | -177.10%-872K | 1.02%1.98M | 99.22%1.54M |
Effect of exchange rate changes | -100.00%-2K | --0 | 103.70%1K | 71.43%-2K | 114.29%1K | ---1K | --25K | ---27K | ---7K | ---7K |
End cash Position | 118.23%1.9M | -19.92%1.26M | -92.05%261K | -87.95%504K | -87.95%504K | -67.13%872K | -34.13%1.57M | -1.65%3.28M | 89.49%4.18M | 89.49%4.18M |
Free cash from | 1,742.03%1.13M | 97.44%-63K | -67.92%51K | -141.50%-1.68M | -69.30%693K | -113.97%-69K | -3,421.43%-2.47M | -88.41%159K | 207.28%4.05M | -48.19%2.26M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data